Clinical trialObsCompleted
Oncologic Safety and Lymphadenectomy in Parenchyma-Sparing Resection for SPN
Parenchyma-Sparing Resection for Pancreatic Solid Pseudopapillary Neoplasm: Oncologic Safety and Role of Lymphadenectomy in a Prospective Cohort Study
- Outcome
- Finished, no results posted
- Phase
- Obs
- Status
- Completed
- Study type
- Observational
- Start
- 1 July 2008
- Expected end
- 1 March 2026
- Enrollment
- 708 participants
- Sites
- 1
- Primary outcomes
- Reoperation rate; Rate of pancreatic enzyme-dependent malabsorption; Rate of new-onset diabetes; R0 resection rate; Recurrence-free survival (RFS)
- Sponsor
- Other
- Results posted
- No
- Last update
- 18 May 2026
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Papers 4
- Registry-listed results paperMolecular profiling reveals the malignant potential in solid pseudopapillary neoplasms of the pancreas. DOI 10.1016/j.canlet.2025.217788↗
- Registry-listed results paperLong-term Survival, Quality of Life, and Molecular Features of the Patients With Solid Pseudopapillary Neoplasm of the … DOI 10.1097/sla.0000000000005842↗
- Registry-listed results paperLong-term Outcomes of Parenchyma-sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocr… DOI 10.1097/sla.0000000000005559↗
- BackgroundElevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish… DOI 10.1016/s0022-2275(20)32447-0↗
The registry lists these as results papers; in a hand check of 27 such links about 78% reported the trial’s results, so read the paper before treating it as the outcome.